PubRank

Anne A Gershon

Author PubWeight™ 48.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for the management of herpes zoster. Clin Infect Dis 2007 4.33
2 Effectiveness over time of varicella vaccine. JAMA 2004 2.52
3 Varicella vaccine--are two doses better than one? N Engl J Med 2002 2.40
4 Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis 2008 2.37
5 Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009 2.13
6 Preventing varicella-zoster disease. Clin Microbiol Rev 2005 1.55
7 The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008 1.50
8 Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 2011 1.45
9 Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 2004 1.45
10 A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol 2009 1.42
11 Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Vaccine 2011 1.39
12 Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol 2003 1.34
13 Consensus: varicella vaccination of healthy children--a challenge for Europe. Pediatr Infect Dis J 2004 1.28
14 Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol 2011 1.28
15 Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis 2004 1.19
16 Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis 2006 1.17
17 Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis 2008 1.17
18 Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis 2010 1.14
19 Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis 2010 1.14
20 The history and mystery of VZV in saliva. J Infect Dis 2011 1.10
21 Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci U S A 2006 1.09
22 An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J Med Virol 2005 1.09
23 Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics 2007 1.02
24 Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol 2010 0.93
25 The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation. J Virol 2006 0.92
26 Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient. Am J Infect Control 2011 0.90
27 Varicella vaccine. N Engl J Med 2007 0.89
28 Risk of herpes zoster in adults immunized with varicella vaccine. J Infect Dis 2008 0.86
29 VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol 2010 0.85
30 Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system. J Neurovirol 2014 0.85
31 Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions. J Infect Dis 2006 0.85
32 Varicella vaccine: rare serious problems--but the benefits still outweigh the risks. J Infect Dis 2003 0.84
33 Transmission of varicella vaccine virus to a non-family member in China. Vaccine 2010 0.83
34 Neonatal herpes simplex infection and the Three Musketeers. N Engl J Med 2011 0.82
35 DNA sequence variability in Oka vaccine isolates. J Infect Dis 2007 0.80
36 The impact of varicella vaccination in the United States. Semin Pediatr Infect Dis 2005 0.79
37 Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days. Infect Control Hosp Epidemiol 2010 0.77
38 Varicella vaccine for susceptible adults: do it today. Clin Infect Dis 2004 0.76
39 The Oka varicella vaccines are more equal than different. Vaccine 2004 0.75
40 Guidelines for quality standards for immunization. Clin Infect Dis 2002 0.75